Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$11.3K Buy
825
+39
+5% +$537 ﹤0.01% 1596
2024
Q4
$9.31K Sell
786
-667
-46% -$10.5K ﹤0.01% 1691
2024
Q3
$26.1K Buy
1,453
+283
+24% +$5.16K ﹤0.01% 1146
2024
Q2
$20.6K Buy
1,170
+101
+9% +$2.09K ﹤0.01% 1230
2024
Q1
$27.4K Sell
1,069
-5
-0.5% -$125 ﹤0.01% 1053
2023
Q4
$28K Buy
1,074
+245
+30% +$5.59K ﹤0.01% 1005
2023
Q3
$19.1K Sell
829
-1
-0.1% -$25 ﹤0.01% 1078
2023
Q2
$19.5K Buy
830
+108
+15% +$1.83K ﹤0.01% 1105
2023
Q1
$8.57K Buy
722
+561
+348% +$7.99K ﹤0.01% 1548
2022
Q4
$2.47K Buy
161
+1
+0.6% +$17 ﹤0.01% 2151
2022
Q3
$3K Buy
160
+95
+146% +$1.89K ﹤0.01% 1949
2022
Q2
$1K Buy
65
+10
+18% +$230 ﹤0.01% 2410
2022
Q1
$2K Buy
+55
New +$1.72K ﹤0.01% 2111

Other funds holding XP

Lindbrook Capital's XP Position: Q1 2025 in Review

Lindbrook Capital increased its XP (XP) stake by 5% in Q1 2025, buying an estimated $537 and bringing the position to 825 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Lindbrook Capital first reported a position in XP in Q1 2022 and has held it in 13 quarters since. The position peaked at $28K in Q4 2023. 296 funds tracked by Wall St. Rank hold XP as of Q1 2025.

  • Lindbrook Capital held 825 shares of XP worth $11.3K as of Q1 2025.
  • Lindbrook Capital bought 39 XP shares in Q1 2025, an estimated $537.
  • XP made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1596 holding.
  • Lindbrook Capital first reported a position in XP in Q1 2022 and has held it in 13 quarters since.
  • Lindbrook Capital's XP position peaked at $28K in Q4 2023.
  • 296 funds tracked by Wall St. Rank held XP as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.